$0.1050
At close: Jun 9, 5:00 PM EST
Get the latest news on PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. performance